The main objective of this study was to assess NT-proBNP levels to evaluate the prevalence of HS and its associated factors in outpatients affected by T2DM and arterial hypertension or high-normal BP who were eligible for SGLT2i and/or GLP1-RA treatment. The gene discussed is NPPB; the disease is Hypertension.